Table 3 Patient OCS-dependence comorbidities in OCS-dependent patients.a
From: Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
Diagnosis description | Patients (N = 544) |
|---|---|
Any condition, n (%) | 291 (53) |
Psychopathologies, n (%) | Â |
 Any condition | 136 (25) |
 Anxiety | 55 (10) |
 Depression | 55 (10) |
 Mood changes | 40 (7) |
 Sleep disorders | 68 (13) |
Osteoporosis/bone fractures, n (%) | Â |
 Any condition | 108 (20) |
 Bone fractures | 5 (< 1) |
 Osteoporosis | 107 (20) |
Weight gain, n (%) | 91 (17) |
Adrenal-related, n (%) | Â |
 Any condition | 59 (11) |
 Adrenal suppression | 18 (3) |
 Cushing’s syndrome | 20 (4) |
 Moon face | 41 (8) |
Bruising, n (%) | 59 (11) |
Eye-related, n (%) | Â |
 Any condition | 54 (10) |
 Glaucoma | 12 (2) |
 Cataract | 44 (8) |